GLP1R and type 2 diabetes mellitus: Second, as mentioned above, the glucose-lowering strategies used in the ACCORD study (primarily sulfonylureas and insulin) differed from current strategies for managing blood glucose in patients with type 2 diabetes, which increasingly utilize SGLT2 inhibitors and GLP-1 receptor agonists.